MiR-588 acts as an oncogene in ovarian cancer and increases the radioresistance of ovarian cancer cells
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Radiation Research"
DOI: 10.1093/jrr/rrad033
Abstract: Abstract The therapeutic outcomes of ovarian cancer (OVCA) patients are majorly limited by the development of acquired chemo/radioresistance and the lack of targeted therapies. Accumulating studies demonstrate that microRNAs are involved in tumorigenesis and radioresistance.… read more here.
Keywords: mir 588; ovarian cancer; ovca cells; ovca ... See more keywords